Summit Partners, L.P. has filed an updated Schedule 13G/A with the SEC, revealing its stake in LifeStance Health Group, Inc. This filing, dated November 13, 2026, shows that Summit Partners holds a total of 16,623,824 shares, representing approximately 4.37% of the company’s common stock. This significant investment highlights Summit's commitment to the health services sector.

LifeStance Health Group, Inc. operates within the health services industry, specifically classified under SIC code 8000. The company is listed on the Nasdaq exchange under the ticker LFST. This update is particularly relevant as the health services industry continues to evolve, with increasing demand for mental health services and innovative treatment solutions.

The filing details that Summit Partners, L.P. and its affiliated entities, including Summit Partners Growth Equity Fund IX-A, L.P. and Summit Partners Growth Equity Fund IX-B, L.P., collectively hold the shares. The document states, “*Calculated based on 380,190,724 shares of common stock... outstanding as of October 28, 2026.” This information underscores the scale of Summit's investment and its potential influence on LifeStance's strategic direction.

This update may affect various stakeholders, including investors, competitors, and market analysts. LifeStance's competitors in the health services sector will likely keep a close eye on Summit's actions, as their investment may signal confidence in LifeStance's future growth and operational strategies.

The filing does not specify any immediate next steps or actions related to this update. However, it does indicate that Summit Partners remains actively engaged in managing its investments within the health services sector.